MX2011010616A - Metodos para tratar edema relacionado a isquemia-reperfusion. - Google Patents

Metodos para tratar edema relacionado a isquemia-reperfusion.

Info

Publication number
MX2011010616A
MX2011010616A MX2011010616A MX2011010616A MX2011010616A MX 2011010616 A MX2011010616 A MX 2011010616A MX 2011010616 A MX2011010616 A MX 2011010616A MX 2011010616 A MX2011010616 A MX 2011010616A MX 2011010616 A MX2011010616 A MX 2011010616A
Authority
MX
Mexico
Prior art keywords
reperfusion
methods
isemaem
edem
treat
Prior art date
Application number
MX2011010616A
Other languages
English (en)
Spanish (es)
Inventor
Thomas Michael Egan
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Publication of MX2011010616A publication Critical patent/MX2011010616A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10Preservation of living parts
    • A01N1/12Chemical aspects of preservation
    • A01N1/122Preservation or perfusion media
    • A01N1/126Physiologically active agents, e.g. antioxidants or nutrients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
MX2011010616A 2009-04-09 2010-04-09 Metodos para tratar edema relacionado a isquemia-reperfusion. MX2011010616A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16808909P 2009-04-09 2009-04-09
PCT/US2010/030556 WO2010118334A1 (en) 2009-04-09 2010-04-09 Methods of treating edema related to ischemia-reperfusion

Publications (1)

Publication Number Publication Date
MX2011010616A true MX2011010616A (es) 2012-03-14

Family

ID=42936599

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011010616A MX2011010616A (es) 2009-04-09 2010-04-09 Metodos para tratar edema relacionado a isquemia-reperfusion.

Country Status (14)

Country Link
US (1) US20120064044A1 (https=)
EP (1) EP2416651A4 (https=)
JP (1) JP2012523432A (https=)
KR (1) KR20120005025A (https=)
CN (1) CN102458113A (https=)
AU (1) AU2010233151A1 (https=)
BR (1) BRPI1010516A2 (https=)
CA (1) CA2757998A1 (https=)
EA (1) EA201101349A1 (https=)
IL (1) IL215604A0 (https=)
MX (1) MX2011010616A (https=)
SG (1) SG175133A1 (https=)
WO (1) WO2010118334A1 (https=)
ZA (1) ZA201107815B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0911195A2 (pt) * 2008-04-09 2017-06-20 The Univ Of North Caroline At Chapel Hill métodos de regulação de arranjo de citoesqueleto de actina e formação de gap intracelular
CN103492572A (zh) 2011-03-03 2014-01-01 夸克医药公司 用于治疗肺疾病和损伤的组合物和方法
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof
CN110446511B (zh) 2017-03-10 2024-04-02 北卡罗来纳大学查珀尔希尔分校 短效的基于肝素的抗凝血剂化合物和方法
WO2019010216A1 (en) 2017-07-03 2019-01-10 The University Of North Carolina At Chapel Hill ENZYMATIC SYNTHESIS OF HOMOGENEOUS CHONDROITIN SULFATE OLIGOSACCHARIDES
JP7495061B2 (ja) 2017-11-03 2024-06-04 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル 抗炎症作用を有する硫酸化オリゴ糖
ES2985591T3 (es) 2018-02-12 2024-11-06 Inimmune Corp Ligandos de receptores tipo Toll
CN112437667B (zh) 2018-06-20 2024-05-28 北卡罗来纳大学查珀尔希尔分校 细胞保护方法和组合物
WO2021097345A1 (en) * 2019-11-13 2021-05-20 The University Of North Carolina At Chapel Hill Heparan sulfate (hs) oligosaccharides effect in liver ischemia reperfusion injury

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05139992A (ja) * 1991-11-13 1993-06-08 Ajinomoto Co Inc ヒトadfを含有する臓器保護剤
US6113918A (en) * 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US7960522B2 (en) * 2003-01-06 2011-06-14 Corixa Corporation Certain aminoalkyl glucosaminide phosphate compounds and their use
JPWO2004085396A1 (ja) * 2003-03-26 2006-06-29 三菱ウェルファーマ株式会社 虚血再灌流障害の予防または治療剤、臓器保存剤およびスクリーニング方法
US20060211752A1 (en) * 2004-03-16 2006-09-21 Kohn Leonard D Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
US7928132B2 (en) * 2004-08-06 2011-04-19 Ohio University Methods for the amelioration of episodes of acute or chronic ulcerative colitis
US8734788B2 (en) * 2007-08-03 2014-05-27 Opsona Therapeutics Ltd Composition and method for treatment of reperfusion injury and tissue damage
BRPI0911195A2 (pt) * 2008-04-09 2017-06-20 The Univ Of North Caroline At Chapel Hill métodos de regulação de arranjo de citoesqueleto de actina e formação de gap intracelular

Also Published As

Publication number Publication date
AU2010233151A1 (en) 2011-11-17
JP2012523432A (ja) 2012-10-04
EP2416651A1 (en) 2012-02-15
US20120064044A1 (en) 2012-03-15
SG175133A1 (en) 2011-12-29
WO2010118334A1 (en) 2010-10-14
KR20120005025A (ko) 2012-01-13
BRPI1010516A2 (pt) 2015-08-25
CN102458113A (zh) 2012-05-16
EP2416651A4 (en) 2014-03-26
ZA201107815B (en) 2013-04-24
IL215604A0 (en) 2011-12-29
CA2757998A1 (en) 2010-10-14
EA201101349A1 (ru) 2012-05-30

Similar Documents

Publication Publication Date Title
MX2011010616A (es) Metodos para tratar edema relacionado a isquemia-reperfusion.
CL2018001223A1 (es) Locus óptimo de la soja (divisional de solicitud 201601063)
CR20110560A (es) Métodos de tratamiento para tumores sólidos
CR20110686A (es) Pirimidinonas como ihnibidores de pi3k
UY33627A (es) Compuestos para tratar enfermedades neurodegenerativas
ECSP12012230A (es) Proteína de fusión robo1-fc y su utilización en el tratamiento de tumores
ECSP11010778A (es) Amidofenoxiindazoles útiles como inhibidores de c-met
UY34165A (es) ?compuestos aldh-2 mitocondriales humanos para el tratamiento de la adicción?.
PA8841901A1 (es) Compuestos orgánicos
NI201500088A (es) Inhibidores de histona desmetilasa
GT200800202A (es) Quinazolinas para la inhibicion de pdk1
CR11485A (es) Tratamiento de cancer de mama con un inhibidor de parp solo o en combinacion con agentes anti-tumorales
MX2010009765A (es) Moleculas pequeñas que contienen boro como agentes anti-inflamatorios.
BR112012019302A2 (pt) imidazo[1,2-b][1,2,4]triazinas como inibidores de c-met
CR20170071A (es) Compuestos terapeuticos y composiciones
CR20110326A (es) Compuestos pirazina como inhibidores de fosfodiesterasa 10
AR082340A1 (es) Metodos y composiciones para la terapia del cancer de higado
CR11870A (es) Composiciones de perácido y 2-hidroxi ácido orgánico y métodos para tratar productos agrícolas
BRPI1000320B8 (pt) Composições e métodos para tratar sinais de envelhecimento da pele
NI201900009A (es) MÉTODOS PARA TRATAR EL CÁNCER DE PRÓSTATA Se describen métodos para tratar el c
MX2012007032A (es) Composiciones organicas para tratar las enfermedades relacionadas con hsf1.
BR112012023836A2 (pt) composto tricíclicos e inibidores de pbk contendo os mesmos
EA201170294A1 (ru) Способы лечения реперфузионных повреждений
UY34466A (es) Proceso para estabilizar contenido bacteriano de treparaciones minerales acuosas que comprenden carbbonatos de calcio.
GT201200345A (es) Compuestos heterocìclicos, su preparaciòn y su aplicaciòn terapèutica

Legal Events

Date Code Title Description
FA Abandonment or withdrawal